Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Tag Archives: Survival
Another Option in the Second Line Treatment of Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
Docetaxel(Taxotere) has long been considered the standard of care for second-line treatment of advanced NSCLC. However, the disadvantage of using this agent include the need to administer it with corticosteroid premedication and its toxicity profile A new study published in … Continue reading
Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer
Tagged docetaxel, Javlor, Non small cell lung cancer, NSCLC, Survival, Taxotere, Treatment, vinflunine
Comments Off on Another Option in the Second Line Treatment of Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
Pancreatic cancer – Causes, Prevention, Prognosis, Diagnosis and Latest Treatment
Prevalence Pancreatic cancer is the fourth most common cause of adult cancer death, accounting for an estimated 42,470 new cases and 35,240 deaths in USA for 2009. The high mortality rate is due to the high incidence of metastatic disease … Continue reading
Posted in Pancreatic Cancer
Tagged Avastin, bevacizumab, capecitabine, Causes, Diagnosis, Eloxatin, erlotinib, gemcitabine, Gemzar, oxaliplatin, Pancreatic Cancer, Prevention, Prognosis, Survival, Tarceva, Treatment, Xeloda
2 Comments
Gefitinib Improves Progression-Free Survival in Metastatic Breast Cancer
According to a new study published in the Clinical Cancer Research, adding epidermal growth factor receptor (EGFR) inhibitor gefitinib (Iressa) to anastrozole (Arimidex) improved progression-free survival in postmenopausal women with hormone receptor-positive metastatic breast cancer. The study randomized 93 postmenopausal … Continue reading
Posted in Breast cancer, Cancer
Tagged anastrozole, Arimidex, Breast cancer, gefitinib, Iressa, Survival
Comments Off on Gefitinib Improves Progression-Free Survival in Metastatic Breast Cancer
New Standard Treatment for Advanced Biliary Tract Cancer: Cisplatin Plus Gemcitabine
Good news for patients with advanced biliary tract cancer. Combination of cisplatin and gemcitabine (Gemzar) have been shown to be an effective treatment option for patients with locally advanced or metastatic biliary tract cancer. In developed nations, biliary tract cancer … Continue reading
Posted in Cancer, Gallbladder cancer
Tagged Biliary tract cancer, cholangiocarcinoma, Cisplatin, gallbladder cancer, gemcitabine, Gemzar, Survival
Comments Off on New Standard Treatment for Advanced Biliary Tract Cancer: Cisplatin Plus Gemcitabine
Taking Aspirin Can Also Improve Survival after Breast Cancer
Previously, we have the beneficial effect of Aspirin in reducing in the death among colorectal cancer patients. Now, a prospective, observational study published in the March issue of the Journal of Clinical Oncology suggested that aspirin can also lower the … Continue reading
Posted in Breast cancer, Cancer
Tagged Aspirin, Breast cancer, Survival
Comments Off on Taking Aspirin Can Also Improve Survival after Breast Cancer
Alternative 1st Treatment for Small-Cell Lung Cancer Patients with Extensive Disease
Lung cancer is the most common diagnosed cancer worldwide and small-cell lung cancer (SCLC) accounts for only 10%-15% of lung cancer cases. Etoposide in combination with cisplatin (EP) or carboplatin is currently considered the standard of care in most countries, but … Continue reading
Posted in Cancer, Lung Cancer
Tagged 1st line, Cisplatin, Etoposide, Irinotecan, Small Cell Lung Cancer, Survival, Treatment
Comments Off on Alternative 1st Treatment for Small-Cell Lung Cancer Patients with Extensive Disease
Best Regimen Sequence for Early Breast Cancer patients
Which is the best chemotherapy adjuvant regimen sequence for early breast cancer? It is widely known that anthracyclines (epirubicin and doxorubicin) and taxanes is the best adjuvant chemotherapy regimen for early breast cancer. However, should anthracyclines be always administered before taxanes? An article published … Continue reading
Posted in Breast cancer, Cancer
Tagged adjuvant, anthracyclines, Breast cancer, chemotherapy, early, regimen, Survival, taxanes
Comments Off on Best Regimen Sequence for Early Breast Cancer patients
Alternative Treatment Options for Late Stage Lung Cancer Patients
Paclitaxel plus carboplatin(PC) is the current standard regimen for advanced or metastatic non-small-cell lung cancer (NSCLC) patients. However, paclitaxel is associated with serious toxicity such as peripheral neuropathy. A tria,l published in October version of the Annals of Oncology, was … Continue reading
Posted in Cancer, Lung Cancer
Tagged carboplatin, chemotherapy, gemcitabine, Lung Cancer, NSCLC, paclitaxel, Stage III, Stage IV, Survival
Comments Off on Alternative Treatment Options for Late Stage Lung Cancer Patients
New Drug Offer Hope to Patients with Late Stage Prostate Cancer
At present, metastatic and hormonal-refractory prostate cancer patients who have failed 1st line chemotherapy will be given mitoxantrone plus prednisone as the salvage therapy. However, mitoxantrone plus prednisone is not very effective in controlling metastatic prostate cancer. Now, a new … Continue reading
Posted in Cancer, Prostate cancer
Tagged chemotherapy, Prostate cancer, Survival
Comments Off on New Drug Offer Hope to Patients with Late Stage Prostate Cancer
